History of Endocrine-Related Cancer

Image Source-Google | Image by- | medicine.wisc

• Endocrine-Related Cancer was founded as Reviews on Endocrine-Related Cancer, the in-house journal of Zeneca (now AstraZeneca) posted by using its discern business enterprise ICI Pharmaceuticals. It changed into taken over via the Society for Endocrinology in 1994 when it changed into renamed, and the remit become prolonged to consist of a limited wide variety of unique research articles to complement the existing opinions. The numbers of studies articles regularly multiplied through the years.

• The editor-in-chief of the magazine on the time of the name exchange and remit extension changed into Vivian H.T. James, who took the magazine’s precursor and set Endocrine-Related Cancer on a firm footing for development and enlargement. Marc Lippman took over leadership in 2000 and managed the fourfold boom in posted pages. He also oversaw an effect factor increase from zero.933 in 1999 to four.597 in 2004.

• In 2006, Endocrine-Related Cancer changed into followed as an respectable magazine through the European Society of Endocrinology, in 2015 by the Japan Hormone and Cancer Society and in 2021 by way of the Endocrine Society of Australia. James Fagin held the position of editor-in-chief from 2006 to 2010. During this time the effect element rose to 5.236.

• There had been four annual problems of the journal from 1994 to 2010. From 2011 to 2015 Endocrine-Related Cancer changed into posted bimonthly and, as of 2017, is published month-to-month.